keyword
https://read.qxmd.com/read/38701193/the-immunoglobulin-superfamily-ligand-b7h6-subjects-t-cell-responses-to-nk-cell-surveillance
#1
JOURNAL ARTICLE
Michael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, David Vonhören, Selina Jansky, Julius Michel, Anna Keib, Saskia Stange, Nicolaj Hackert, Niklas Kehl, Markus Hahn, Antje Habel, Stefanie Jung, Kristine Jähne, Felix Sahm, Johannes Betge, Adelheid Cerwenka, Frank Westermann, Peter Dreger, Marc S Raab, Nadja M Meindl-Beinker, Matthias Ebert, Lukas Bunse, Carsten Müller-Tidow, Michael Schmitt, Michael Platten
Understanding the mechanisms that regulate T cell immunity is critical for the development of effective therapies for diseases associated with T cell dysfunction, including autoimmune diseases, chronic infections, and cancer. Co-inhibitory "checkpoint molecules," such as programmed cell death protein-1, balance excessive or prolonged immune activation by T cell-intrinsic signaling. Here, by screening for mediators of natural killer (NK) cell recognition on T cells, we identified the immunoglobulin superfamily ligand B7H6 to be highly expressed by activated T cells, including patient-infused CD19-targeting chimeric antigen receptor (CAR) T cells...
May 3, 2024: Science Immunology
https://read.qxmd.com/read/38700835/emerging-innate-immune-cells-in-cancer-immunotherapy-promises-and-challenges
#2
REVIEW
Jennifer Wu
Immune checkpoint inhibitor (ICI)-based therapy has made an unprecedented impact on survival benefit for a subset of cancer patients; however, only a subset of cancer patients is benefiting from ICI therapy if all cancer types are considered. With the advanced understanding of interactions of immune effector cell types and tumors, cell-based therapies are emerging as alternatives to patients who could not benefit from ICI therapy. Pioneering work of chimeric antigen receptor T (CAR-T) therapy for hematological malignancies has brought encouragement to a broad range of development for cellular-based cancer immunotherapy, both innate immune cell-based therapies and T-cell-based therapies...
May 3, 2024: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/38698750/circulating-immune-cells-predict-prognosis-and-clinical-response-to-chemotherapy-in-cholangiocarcinoma
#3
JOURNAL ARTICLE
Huina Shi, Zhaosheng Li, Mingchen Zhu
BACKGROUND: The immune system is linked to the prognosis and response to treatment of patients with cancer. However, the clinical implication of peripheral blood immune cells in cholangiocarcinoma (CCA) remains vague. Thus, we aimed to assess whether peripheral circulating immune cells could be used as an indicator for prognosis and chemotherapeutic efficacy in CCA. METHODS: The distributions of immune subsets were analyzed in peripheral blood samples from 141 patients with CCA and 131 healthy volunteers by using flow cytometry...
May 2, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38698481/the-chronic-leukocyte-and-inflammatory-cytokine-responses-of-older-adults-to-resistance-training-in-normobaric-hypoxia-a-randomized-controlled-trial
#4
JOURNAL ARTICLE
Giselle Larissa Allsopp, Alex Bernard Addinsall, Garth Stephenson, Faiza Basheer, Paul Adrian Della Gatta, Samantha May Hoffmann, Aaron Paul Russell, Craig Robert Wright
TRIAL DESIGN: Older adults experience chronic dysregulation of leukocytes and inflammatory cytokines, both at rest and in response to resistance training. Systemic hypoxia modulates leukocytes and cytokines, therefore this study characterized the effects of normobaric hypoxia on the leukocyte and cytokine responses of older adults to resistance training. METHODS: 20 adults aged 60-70 years performed eight weeks of moderate-intensity resistance training in either normoxia or normobaric hypoxia (14...
May 2, 2024: BMC Sports Science, Medicine and Rehabilitation
https://read.qxmd.com/read/38698250/short-term-nonsurgical-periodontal-therapy-boosts-interleukin-12-levels-and-reduces-oral-cancer-risk
#5
JOURNAL ARTICLE
Hazza A Alhobeira, Anamika Sharma, Ananya Sharma, Mahvish Khan, Mohtashim Lohani, Saif Khan, Eslam K Fahmy, Safya E Esmaeel, Anshoo Agarwal
BACKGROUND: Cytokines, including interleukin-12 (IL-12), are proteins that regulate cell survival, proliferation, differentiation, and function. IL-12 is a heterodimeric proinflammatory cytokine. It possesses tumoricidal properties and promotes M1 macrophage polarization and IFN-γ production by T helper (Th1) cells, which in turn stimulates the antitumor cytotoxic cluster of eight positive (CD8+) and natural killer cells, therefore activating an effector immune response against tumor cells...
May 3, 2024: Irish Journal of Medical Science
https://read.qxmd.com/read/38697554/absence-of-atm-leads-to-altered-nk-cell-function-in-mice
#6
JOURNAL ARTICLE
Daniela Angela Covino, Maria Giovanna Desimio, Alessandro Giovinazzo, Bruna Sabino Pinho de Oliveira, Matilde Merolle, Daniela Marazziti, Manuela Pellegrini, Margherita Doria
Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm-/- ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm-/- littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor-produced TNF-α...
April 30, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38697317/alpha-galactosylceramide-improves-the-potency-of-mrna-lnp-vaccines-against-cancer-and-intracellular-bacteria
#7
JOURNAL ARTICLE
Sofie Meulewaeter, Ilke Aernout, Joke Deprez, Yanou Engelen, Margo De Velder, Lorenzo Franceschini, Karine Breckpot, Serge Van Calenbergh, Caroline Asselman, Katie Boucher, Francis Impens, Stefaan C De Smedt, Rein Verbeke, Ine Lentacker
Although various types of mRNA-based vaccines have been explored, the optimal conditions for induction of both humoral and cellular immunity remain rather unknown. In this study, mRNA vaccines of nucleoside-modified mRNA in lipoplexes (LPXs) or lipid nanoparticles (LNPs) were evaluated after administration in mice through different routes, assessing mRNA delivery, tolerability and immunogenicity. In addition, we investigated whether mRNA vaccines could benefit from the inclusion of the adjuvant alpha-galactosylceramide (αGC), an invariant Natural Killer T (NKT) cell ligand...
April 30, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38697116/a-ctcf-binding-site-in-the-mdm1-il22-ifng-locus-shapes-cytokine-expression-profiles-and-plays-a-critical-role-in-early-th1-cell-fate-specification
#8
JOURNAL ARTICLE
Chunhong Liu, Hiroyuki Nagashima, Nilisha Fernando, Victor Bass, Jaanam Gopalakrishnan, Sadie Signorella, Will Montgomery, Ai Ing Lim, Oliver Harrison, Lauren Reich, Chen Yao, Hong-Wei Sun, Stephen R Brooks, Kan Jiang, Vijayaraj Nagarajan, Yongbing Zhao, Seolkyoung Jung, Rachael Phillips, Yohei Mikami, Caleb A Lareau, Yuka Kanno, Dragana Jankovic, Martin J Aryee, Aleksandra Pękowska, Yasmine Belkaid, John O'Shea, Han-Yu Shih
Cytokine expression during T cell differentiation is a highly regulated process that involves long-range promoter-enhancer and CTCF-CTCF contacts at cytokine loci. Here, we investigated the impact of dynamic chromatin loop formation within the topologically associating domain (TAD) in regulating the expression of interferon gamma (IFN-γ) and interleukin-22 (IL-22); these cytokine loci are closely located in the genome and are associated with complex enhancer landscapes, which are selectively active in type 1 and type 3 lymphocytes...
April 26, 2024: Immunity
https://read.qxmd.com/read/38697105/next-generation-anti-pd-l1-il-15-immunocytokine-elicits-superior-antitumor-immunity-in-cold-tumors-with-minimal-toxicity
#9
JOURNAL ARTICLE
Wenqiang Shi, Nan Liu, Zexin Liu, Yuqi Yang, Qiongya Zeng, Yang Wang, Luyao Song, Fang Hu, Jin Fu, Junsheng Chen, Mingyuan Wu, Lin Zhou, Fengping Zhu, Likun Gong, Jianwei Zhu, Long Jiang, Huili Lu
The clinical applications of immunocytokines are severely restricted by dose-limiting toxicities. To address this challenge, here we propose a next-generation immunocytokine concept involving the design of LH05, a tumor-conditional anti-PD-L1/interleukin-15 (IL-15) prodrug. LH05 innovatively masks IL-15 with steric hindrance, mitigating the "cytokine sink" effect of IL-15 and reducing systemic toxicities associated with wild-type anti-PD-L1/IL-15. Moreover, upon specific proteolytic cleavage within the tumor microenvironment, LH05 releases an active IL-15 superagonist, exerting potent antitumor effects...
April 25, 2024: Cell reports medicine
https://read.qxmd.com/read/38697104/artificial-intelligence-for-diagnosis-and-prognosis-prediction-of-natural-killer-t-cell-lymphoma-using-magnetic-resonance-imaging
#10
JOURNAL ARTICLE
YuChen Zhang, YiShu Deng, QiHua Zou, BingZhong Jing, PeiQiang Cai, XiaoPeng Tian, Yu Yang, BingZong Li, Fang Liu, ZhiHua Li, ZaiYi Liu, ShiTing Feng, TingSheng Peng, YuJun Dong, XinYan Wang, GuangYing Ruan, Yun He, ChunYan Cui, Jiao Li, Xiao Luo, HuiQiang Huang, HaoHua Chen, SongQi Li, Ying Sun, ChuanMiao Xie, Liang Wang, ChaoFeng Li, QingQing Cai
Accurate diagnosis and prognosis prediction are conducive to early intervention and improvement of medical care for natural killer/T cell lymphoma (NKTCL). Artificial intelligence (AI)-based systems are developed based on nasopharynx magnetic resonance imaging. The diagnostic systems achieve areas under the curve of 0.905-0.960 in detecting malignant nasopharyngeal lesions and distinguishing NKTCL from nasopharyngeal carcinoma in independent validation datasets. In comparison to human radiologists, the diagnostic systems show higher accuracies than resident radiologists and comparable ones to senior radiologists...
April 25, 2024: Cell reports medicine
https://read.qxmd.com/read/38694959/preclinical-evaluation-of-therapeutic-vaccines-for-chronic-hepatitis-b-that-stimulate-antiviral-activities-of-t-cells-and-nkt-cells
#11
JOURNAL ARTICLE
Anna H Mooney, Sarah L Draper, Olivia K Burn, Regan J Anderson, Benjamin J Compton, Chingwen Tang, Kathryn J Farrand, Pietro Di Lucia, Micol Ravà, Valeria Fumagalli, Leonardo Giustini, Elisa Bono, Dale I Godfrey, William R Heath, Weiming Yuan, Francis V Chisari, Luca G Guidotti, Matteo Iannacone, John Sidney, Alessandro Sette, Shivali A Gulab, Gavin F Painter, Ian F Hermans
BACKGROUND & AIMS: Liver diseases resulting from chronic HBV infection are a significant cause of morbidity and mortality. Vaccines that elicit T-cell responses capable of controlling the virus represent a treatment strategy with potential for long-term effects. Here, we evaluated vaccines that induce the activity of type I natural killer T (NKT) cells to limit viral replication and license stimulation of conventional antiviral T-cells. METHODS: Vaccines were prepared by conjugating peptide epitopes to an NKT-cell agonist to promote co-delivery to antigen-presenting cells, encouraging NKT-cell licensing and stimulation of T cells...
May 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38690527/pager-scfga-unveiling-cell-functions-and-molecular-mechanisms-in-cell-trajectories-through-single-cell-functional-genomics-analysis
#12
JOURNAL ARTICLE
Fengyuan Huang, Robert S Welner, Jake Y Chen, Zongliang Yue
Background: Understanding how cells and tissues respond to stress factors and perturbations during disease processes is crucial for developing effective prevention, diagnosis, and treatment strategies. Single-cell RNA sequencing (scRNA-seq) enables high-resolution identification of cells and exploration of cell heterogeneity, shedding light on cell differentiation/maturation and functional differences. Recent advancements in multimodal sequencing technologies have focused on improving access to cell-specific subgroups for functional genomics analysis...
2024: Front Bioinform
https://read.qxmd.com/read/38690288/self-sufficient-primary-natural-killer-cells-engineered-to-express-t-cell-receptors-and-interleukin-15-exhibit-improved-effector-function-and-persistence
#13
JOURNAL ARTICLE
Els P van Hees, Laura T Morton, Dennis F G Remst, Anne K Wouters, Astrid Van den Eynde, J H Frederik Falkenburg, Mirjam H M Heemskerk
BACKGROUND: NK cells can be genetically engineered to express a transgenic T-cell receptor (TCR). This approach offers an alternative strategy to target heterogenous tumors, as NK:TCR cells can eradicate both tumor cells with high expression of HLA class I and antigen of interest or HLA class I negative tumors. Expansion and survival of NK cells relies on the presence of IL-15. Therefore, autonomous production of IL-15 by NK:TCR cells might improve functional persistence of NK cells. Here we present an optimized NK:TCR product harnessed with a construct encoding for soluble IL-15 (NK:TCR/IL-15), to support their proliferation, persistence and cytotoxic capabilities...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38687958/t-cell-and-natural-killer-cell-membrane-camouflaged-nanoparticles-for-cancer-and-viral-therapies
#14
REVIEW
Fatma Ozsoy, Mahir Mohammed, Nasrullah Jan, Elif Lulek, Yavuz Nuri Ertas
Extensive research has been conducted on the application of nanoparticles in the treatment of cancer and infectious diseases. Due to their exceptional characteristics and flexible structure, they are classified as highly efficient drug delivery systems, ensuring both safety and targeted delivery. Nevertheless, nanoparticles still encounter obstacles, such as biological instability, absence of selectivity, recognition as unfamiliar elements, and quick elimination, which restrict their remedial capacity. To surmount these drawbacks, biomimetic nanotechnology has been developed that utilizes T cell and natural killer (NK) cell membrane-encased nanoparticles as sophisticated methods of administering drugs...
April 30, 2024: ACS Applied Bio Materials
https://read.qxmd.com/read/38687637/genetic-mutations-and-immune-microenvironment-unveiling-the-connection-to-aml-prognosis
#15
JOURNAL ARTICLE
ZhongLi Hu, YanLi Yang, JiaJia Li, ZhongTing Hu
BACKGROUND: This study aims to investigate the correlation between NK and NKT cell proportion disparities and prognosis in patients with acute myeloid leukemia (AML). METHODS: Forty-four cases of acute myeloid leukemia patients were selected, and flow cytometry was utilized to evaluate the expression of bone marrow NK and NKT cells. Next-generation sequencing technology was employed to detect genetic mutations in these 44 AML patients, and the rates of first induction remission and overall survival were recorded...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38687604/hiv-hbv-co-infection-remodels-the-immune-landscape-and-natural-killer-cell-adcc-functional-responses
#16
JOURNAL ARTICLE
Bo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, Jonida Kokici, Natasha Fisher-Pearson, Noshin Hussain, Stefano D'Anna, Lorenzo Piermatteo, Romina Salpini, Valentina Svicher, Stephanie Kucykowicz, Indrajit Ghosh, Fiona Burns, Sabine Kinloch, Pedro Simoes, Sanjay Bhagani, Patrick T F Kennedy, Mala K Maini, Rachael Bashford-Rogers, Upkar S Gill, Dimitra Peppa
BACKGROUND: HBV and HIV co-infection is a common occurrence globally, with significant morbidity and mortality. Both viruses lead to immune dysregulation including changes in NK cells, a key component of antiviral defense and a promising target for HBV cure strategies. Here we used high-throughput single cell analysis to explore the immune cell landscape in people with HBV mono-infection and HIV/HBV co-infection, on antiviral therapy, with emphasis on identifying the distinctive characteristics of NK cell subsets that can be therapeutically harnessed...
April 30, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38687441/the-influence-of-exercise-on-cancer-risk-the-tumor-microenvironment-and-the-treatment-of-cancer
#17
REVIEW
Anqi He, Yamin Pu, Chengsen Jia, Mengling Wu, Hongchen He, Yong Xia
There are several modifiable factors that can be targeted to prevent and manage the occurrence and progression of cancer, and maintaining adequate exercise is a crucial one. Regular physical exercise has been shown to be a beneficial strategy in preventing cancer, potentially amplifying the effectiveness of established cancer therapies, alleviating certain cancer-related symptoms, and possibly mitigating side effects resulting from treatment. Nevertheless, the exact mechanisms by which exercise affects tumors, especially its impact on the tumor microenvironment (TME), remain uncertain...
April 30, 2024: Sports Medicine
https://read.qxmd.com/read/38686856/utilizing-immunotherapy-towards-achieving-a-functional-cure-for-hiv-1
#18
JOURNAL ARTICLE
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole Schmeltz Søgaard
PURPOSE OF REVIEW: Advancements in antiretroviral therapy (ART) have positively impacted the life expectancy and possibility of living a normal life for people with HIV-1. However, lifelong daily medication is necessary to prevent disease progression. To this end, immunotherapeutic strategies are being tested with the aim of developing a functional cure in which the immune system effectively controls HIV-1 in the absence of ART. RECENT FINDINGS: The most promising advances in achieving sustained HIV-1 remission or cure include broadly neutralizing antibodies (bNAbs) that are administered alone or in combination with other agents...
April 12, 2024: Current Opinion in HIV and AIDS
https://read.qxmd.com/read/38685562/high-dimensional-mass-cytometry-identified-circulating-natural-killer-t-cell-subsets-associated-with-protection-from-cytomegalovirus-infection-in-kidney-transplant-recipients
#19
JOURNAL ARTICLE
Laura Donadeu, Thomas Jouve, Sofia Bin, Susan Hartzell, Elena Crespo, Alba Torija, Marta Jarque, Delphine Kevella, José Zúñiga, Weijia Zhang, Zeguo Sun, Alberto Verlato, Mónica Martínez-Gallo, Cristina Font-Miñarro, Maria Meneghini, Nestor Toapanta, Irina B Torres, Joana Sellarés, Manel Perelló, Hannah Kaminski, Lionel Couzi, Alexandre Loupy, Gaetano La Manna, Francesc Moreso, Paolo Cravedi, Oriol Bestard
Cytomegalovirus (CMV) infection is associated with poor kidney transplant outcomes. While innate and adaptive immune cells have been implicated in its prevention, an in-depth characterization of the in vivo kinetics of multiple cell subsets and their role in protecting against CMV infection has not been achieved. Here, we performed high-dimensional immune phenotyping by mass cytometry, and functional assays, on 112 serially collected samples from CMV seropositive kidney transplant recipients. Advanced unsupervised deep learning analysis was used to assess immune cell populations that significantly correlated with prevention against CMV infection and anti-viral immune function...
April 27, 2024: Kidney International
https://read.qxmd.com/read/38683066/-anything-that-can-go-wrong-cytotoxic-cells-and-their-control-of-epstein-barr-virus
#20
REVIEW
Arturo Gutiérrez-Guerrero, Sara Elva Espinosa-Padilla, Saúl Oswaldo Lugo-Reyes
Epstein-Barr virus (EBV) is an gamma of herpes virus affecting exclusively humans, was the first oncogenic virus described and is associated with over seven different cancers. Curiously, the exchange of genes during viral infections has enabled the evolution of other cellular organisms, favoring new functions and the survival of the host. EBV has been co-evolving with mammals for hundreds of millions of years, and more than 95% of adults have been infected in one moment of their life. The infection is acquired primarily during childhood, in most cases as an asymptomatic infection...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
keyword
keyword
55984
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.